We report a 77-year-old Caucasian man with a 1-year complaint of unexplained visual loss and a 4-year history of prostate cancer. A complete ophthalmologic exam, Goldmann visual fields (GVFs), intravenous fluorescein angiography (IVFA), macular and disc optical coherence tomography (OCT), pattern-reversal visual evoked potentials (PVEPs), and flash electroretinograms (ERGs) were performed. On examination, visual acuity was reduced bilaterally. Fundus exam showed juxtapapillary changes (OS > OD) and, in OS, disc pallor, peripheral RPE dropout and whitish retinal discoloration along the arcades. OCTs were normal OU. Cancer-associated retinopathy (CAR) was suspected. A flash ERG was normal OD and markedly reduced and electronegative OS. An IVFA showed bilateral juxtapapillary staining and changes highly suggestive of sequelae of central retinal artery occlusion (CRAO) OS , in which a cilioretinal artery existed along the papillomacular bundle. GVFs showed bilateral blind spot enlargement and centrocecal scotomas, and PVEPs were delayed. These findings suggested cancer-associated optic neuropathy (CAON), confirmed by presence of anti-optic nerve autoantibodies (auto-Abs). No anti-retinal auto-Abs were found. CAON is a less common paraneoplastic manifestation than CAR and it is rarely observed in association with prostate cancer. A combination of visual function testing methods permitted the recognition, in this highly unusual case, of the concurrent presence of unilateral ERG changes most likely attributable to CRAO complications in OS, in all likelihood unrelated to CAON, and not to be confused with unilateral CAR. Auto-Ab testing in combination with visual function tests helps achieve a better understanding of the pathophysiology of vision loss in paraneoplastic visual syndromes.

In the title compound,[RuCl(C(15)H(11)N(3))(C(12)H(8)N(2)O(4))]ClO(4)·C(2)H(5)OH·H(2)O, the geometry of the ClN(5) coordination set around the Ru(II) atom is close to octa-hedral, but distorted on account of the limited bite angles of the polypyridyl ligands. The complexes are linked by O-H⋯O hydrogen bonds between the carboxyl groups and the crystal lattice water mol-ecules into chains along [110]. Face-to-face stacking inter-actions are formed between terpyridine ligands, with inter-planar separations of 3.66 (1) and 3.42 (1) Å, and between bipyridine-4,4'-dicarb-oxy-lic acid ligands, with inter-planar separations of 3.65 (1) and 3.72 (1) Å. Three O atoms of the perchlorate ion are each disordered equally over two positions. The hy-droxy group of the ethanol mol-ecule is also disordered over two sites with refined occupancies of 0.794 (9) and 0.206 (9).

Suitably functionalized vinylheptafulvenes (VHFs) act as thermoswitches undergoing ring closure to the corresponding dihydroazulenes (DHAs). Here we present the synthesis of a new such thermoswitch incorporating two heptafulvene rings on a dicyanoethylene unit. The synthetic protocol explores both the tropylium species as an electrophile and as a leaving group in the generation of the heptafulvene units. The thermally induced ring closure was enhanced as a result of two accessible sites for the reaction to occur.

The crystal structures of the six dichlorobenzaldehyde isomers, four of them newly determined, are analyzed in terms of the geometry and energies of their intermolecular interactions, quantified using the semi-classical density sums (SCDS-PIXEL) method. A consistent feature in all six structures is molecular stacks propagating along a short crystallographic axis of ca 3.8 Å. The stacks have a closely comparable geometry in each isomer, but the interaction energies between stacked molecules are variable on account of the differing relative positions of the Cl substituents. In the majority of the isomers the stacking interactions are the most stabilizing in the structure. Exceptions are the 2,4- and 3,5-isomers, where more stabilizing interactions are made between stacks. In general, the most stabilizing non-stacking intermolecular interactions in the structures are those involving C-H...O contacts. Observed motifs based on Cl...Cl interactions appear to be largely imposed by the constraints of other more stabilizing intermolecular interactions. The isomeric series displays the following noteworthy features:(i) the 2,3- and 2,6-isomers are isostructural despite having different orientations of the Cl and aldehyde functionalities;(ii) the 2,5-isomer exhibits whole-molecule disorder;(iii) the 2,5- and 3,5-isomers have more than one molecule in the crystallographic asymmetric unit (Z'> 1). These features in particular are considered on the basis of the intermolecular interaction energies.

The monoanionic N(4)O ligand N-methyl-N,N'-bis(2-pyridylmethyl)ethylenediamine-N'-acetate (mebpena(-)) undergoes oxidative C-N bond cleavage in the presence of Co(ii) and O(2). The two resultant fragments are coordinated to the metal ion in the product [Co(III)(2-pyridylformate)(mepena)]ClO(4)(mepena(-)= N-methyl-N'-(2-pyridylmethyl)ethylenediamine-N'-acetato). Bond cleavage does not occur in the presence of chloride ions and [Co(III)(mebpena)Cl](+), containing intact mebpena(-), can be isolated. The oxidative instability of the mebpena(-) in the presence of Co(ii) and air stands in contrast to the oxidative stability of the family of very closely related penta- and hexa-dentate ligands in their cobalt complexes. Cyclic voltammetry on the matched pair [Co(III)Cl(mebpena)](+) and [Co(II)Cl(bztpen)](+), bztpen = N-benzyl-N,N',N'-tris(2-pyridylmethyl)ethylenediamine, shows that substitution of a pyridine donor for a carboxylato donor results in a relatively small cathodic shift of 150 mV in the E°(Co(ii)/Co(iii)) oxidation potential, presumably this is enough to determine the contrasting metal oxidation state in the complexes isolated under ambient conditions. DFT calculations support a proposal that [Co(II)(mebpena)](+) reacts with O(2) to form a Co(iii)-superoxide complex which can abstract an H atom from a ligand methylene C atom as the initial step towards the observed oxidative C-N bond cleavage.

A new procedure for functionalization of the dihydroazulene photoswitch on its seven-membered ring was developed, which has allowed isolation of the first dihydroazulene with a phenyl substituent at position 5 from a mixture of regioisomers. Light-induced ring-opening to the corresponding vinylheptafulvene and the thermal back-reaction was studied in detail.

Inhibitors of the serotonin transporter (SERT) and norepinephrine transporter (NET) are widely used in the treatment of major depressive disorder. Although SERT/NET selectivity is a key determinant for the therapeutic properties of these drugs, the molecular determinants defining SERT/NET selectivity are poorly understood. In this study, the structural basis for selectivity of the SERT selective inhibitor citalopram and the structurally closely related NET selective inhibitor talopram is delineated. A systematic structure-activity relationship study allowed identification of the substituents that control activity and selectivity toward SERT and NET and revealed a common pattern showing that SERT and NET have opposite preference for the stereochemical configuration of these inhibitors. Mutational analysis of nonconserved SERT/NET residues within the central substrate binding site was performed to determine the molecular basis for inhibitor selectivity. Changing only five residues in NET to the complementary residues in SERT transferred a SERT-like affinity profile for R- and S-citalopram into NET, showing that the selectivity of these compounds is determined by amino acid differences in the central binding site of the transporters. In contrast, the activity of R- and S-talopram was largely unaffected by any mutations within the central substrate binding site of SERT and NET and in the outer vestibule of NET, suggesting that citalopram and talopram bind to distinct sites on SERT and NET. Together, these findings provide important insight into the molecular basis for SERT/NET selectivity of antidepressants, which can be used to guide rational development of unique transporter inhibitors with fine-tuned transporter selectivity.

The title compound, C(10)H(24)N(+)·C(8)H(15)O(2)(-), forms a layered structure in which inter-molecular N(+)-H⋯O hydrogen bonds connect anions and cations, forming a two-dimensional network parallel to (010). The n-alkyl chains of the decyl-ammonium cations pack according to an ortho-rhom-bic 'subcell' with approximate dimensions 5.1 × 7.3 Å, and they are significantly distorted from planarity.

The X-ray powder diffractograms of racemic citalopram oxalate and (S)-citalopram oxalate are very similar, but the melting point of the racemate is higher than that of the pure enantiomer. The higher melting point indicates that the racemate is a racemic compound, rather than a conglomerate. The crystal structure of the enantiomer contains two molecules of (S)-citalopram in the asymmetric unit. The conformation of the two molecules is different but they approximate mirror images of each other if the aromatic groups are interchanged. The crystal structure of the racemate is essentially isostructural with that of the enantiomer, having almost the same cell parameters but containing a crystallographic inversion centre that is not retained in the enantiomer structure. The closely-comparable crystal structures permit solid solutions to be formed between racemic and enantiomeric citalopram oxalate. Phase diagrams of the (R)-citalopram and (S)-citalopram oxalate system are constructed, and they show that solid solutions are formed at all ratios of the two enantiomers.

Capillary electrophoresis (CE) and electrospray ionisation (ESI) mass spectra of aqueous solutions of manganese(II) complexes of the monoanions of the pentadentate ligands N-methyl-N'-carboxymethyl-N,N'-bis(2-pyridylmethyl)ethane-1,2-diamine (mcbpen(-)) and N-benzyl-N'-carboxymethyl-N,N'-bis(2-pyridylmethyl)ethane-1,2-diamine (bcbpen(-)), show the presence of a mixture of closely related Mn(II) species, assigned to the mono, di-, tri- and poly-cationic complexes [Mn(II)(L)(H(2)O)](n)(n+), L = mcbpen(-) or bcbpen(-) with n = 1, 2, 3, etc. In solution, these complexes are reversibly oxidized by tert-butyl hydrogen peroxide (TBHP),(NH(4))(2)[Ce(NO(3))(6)], Ce(ClO(4))(4), oxone and [Ru(bipy)(3)](3+) to form metastable (t(½)= min to h) higher valent (hydr)oxide species, showing a collective maximum absorbance at 430 nm. The same species can be produced by [Ru(bipy)(3)](2+)-mediated photooxidization in the presence of an electron acceptor. TBHP oxidation of the complexes, in large excesses of the TBHP, is concurrent with an O(2) evolution with turnovers of up to 1.5 × 10(4) mol of O(2) per mol of [Mn] and calculated rate constants from two series of experiments of 0.039 and 0.026 mol[O(2)] s(-1) M(-2). A 1:1 reaction of TBHP with [Mn] is rate determining and the resultant species is proposed to be the mononuclear, catalytically competent,[Mn(IV)(O)(mcbpen)](+). At very close m/z values [Mn(III)(OH)(mcbpen)](+),[Mn(2)(III/IV)(O)(2)(mcbpen)(2)](+) and [Mn(IV)(2)(O)(2)(mcbpen)(2)](2+) are detected by ESI MS and CE when the concentration of TBHP is comparable to or lower than that of [Mn]. These are conditions that occur post catalysis and these species are derived from [Mn(IV)(O)(mcbpen)](+) through condensation reactions.